Published in J Immunol on January 15, 1995
Comparative effectiveness of incident oral antidiabetic drugs on kidney function. Kidney Int (2012) 1.92
Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol (2012) 1.83
Evidence for anti-inflammatory effects of exercise in CKD. J Am Soc Nephrol (2014) 1.61
Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J (2013) 1.60
Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int (2011) 1.53
Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure. Pediatr Nephrol (2004) 1.44
Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal (2009) 1.30
IL-1β receptor antagonist reduces inflammation in hemodialysis patients. J Am Soc Nephrol (2011) 1.21
Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol (2010) 1.20
Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patients. Am J Kidney Dis (2011) 1.14
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev (2012) 1.07
Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol (2008) 0.97
Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immun Ageing (2011) 0.96
Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics (2007) 0.95
Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure. Nephrol Dial Transplant (2012) 0.94
Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin Exp Immunol (1998) 0.87
CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol (2009) 0.86
Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol (2005) 0.84
TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression. Physiol Rep (2015) 0.84
Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities. Front Immunol (2015) 0.84
Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort. J Pediatr (2012) 0.84
Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients. Clin Exp Immunol (1999) 0.83
[Thrombocytopathy and blood complications in uremia]. Wien Klin Wochenschr (2006) 0.81
Altered molecular repertoire of immune system by renal dysfunction in the elderly: is prediction and targeted prevention in the horizon? EPMA J (2013) 0.81
Acute effects of hemodialysis on oxidative stress parameters in chronic uremic patients: comparison of two dialysis membranes. Int J Nephrol Renovasc Dis (2010) 0.80
IL-1 Inhibition and Vascular Function in CKD. J Am Soc Nephrol (2016) 0.79
Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control. Pharmacoepidemiol Drug Saf (2013) 0.79
Soluble adhesion molecules in children and young adults on chronic hemodialysis. Pediatr Nephrol (2004) 0.79
Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study. J Infect Dis (2015) 0.78
Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease. F1000Prime Rep (2014) 0.78
Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect? Curr Heart Fail Rep (2015) 0.78
Clinical causes of inflammation in peritoneal dialysis patients. Int J Nephrol (2014) 0.77
The Guanine Nucleotide Exchange Factor Brx: A Link between Osmotic Stress, Inflammation and Organ Physiology and Pathophysiology. Expert Rev Endocrinol Metab (2010) 0.77
Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodeling. J Vasc Surg (2014) 0.76
Inflammatory Response to Sorbent Hemodialysis. ASAIO J (2015) 0.75
Inflammation regulates fibroblast growth factor 23 production. Curr Opin Nephrol Hypertens (2016) 0.75
Inflammation, vitamin D and dendritic cell precursors in chronic kidney disease. Clin Exp Immunol (2016) 0.75
Ironing out the cross talk between FGF23 and inflammation. Am J Physiol Renal Physiol (2016) 0.75
Mechanism underlying renal failure caused by pathogenic Candida albicans infection. Biomed Rep (2014) 0.75
Comparison of preemptive kidney transplant recipients with nonpreemptive kidney recipients in single center: 5 years of follow-up. Int J Nephrol Renovasc Dis (2013) 0.75
Posterior reversible encephalopathy syndrome in a uremic patient with autosomal recessive polycystic kidney disease. CEN Case Rep (2015) 0.75
Pro-inflammatory cytokines: a possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients. Clin Kidney J (2015) 0.75
Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease. Indian J Clin Biochem (2008) 0.75
Resolution of sleep-disordered breathing in a dialysis-dependent child post-renal transplantation. Pediatr Nephrol (2010) 0.75
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med (1988) 4.69
Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int (1996) 3.62
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med (2001) 3.56
Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis (2001) 2.69
Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol (1996) 2.43
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
Anti-glomerular-basement-membrane disease after lithotripsy. Lancet (1990) 2.11
High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis (1992) 2.05
Pregnancy during dialysis: case report and management guidelines. Nephrol Dial Transplant (1998) 2.04
Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Respir Dis (1989) 1.99
Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol (1998) 1.97
Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant (2001) 1.90
Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant (1993) 1.85
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.85
Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome. Lancet (1993) 1.72
Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant (2001) 1.69
Sepsis and serum cytokine concentrations. Crit Care Med (1997) 1.63
Treatment of cystinuria. Pediatr Nephrol (1999) 1.56
Advantages of short-lived positron-emitting radioisotopes for intracoronary radiation therapy with liquid-filled balloons to prevent restenosis. J Nucl Med (2001) 1.52
Idiotypic regulation of the immune system. Common idiotypic specificities between idiotypes and antibodies raised against anti-idiotypic antibodies in rabbits. J Exp Med (1979) 1.51
Synovial amyloidosis in patients undergoing long-term hemodialysis. Arthritis Rheum (1985) 1.49
Dialysis arthropathy: outcome after renal transplantation. Am J Med (1995) 1.48
Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. Eur Respir J (2007) 1.45
Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford) (2002) 1.45
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone. Mol Endocrinol (2011) 1.45
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients. Pharmacogenomics J (2009) 1.43
[Respiratory risk in carpenters and cabinet makers]. Rev Mal Respir (2001) 1.41
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clin Pharmacol Ther (2007) 1.39
[Factors determining the choice of a modality of treatment by dialysis: a study of nine dialysis centers]. Nephrologie (2000) 1.39
Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc (1993) 1.37
IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol (2001) 1.33
Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int (1972) 1.33
Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J Immunol (2000) 1.32
Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol (1997) 1.32
Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int (1981) 1.30
A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol (1999) 1.27
Renal granulomatous sarcoidosis: report of six cases. Nephrol Dial Transplant (1990) 1.26
Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int (1991) 1.26
Dialysis-related amyloidosis. Nephrol Dial Transplant (1986) 1.23
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff. Lancet (1981) 1.21
Liver changes and complications in adult polycystic kidney disease. Adv Nephrol Necker Hosp (1985) 1.20
Detection of hepatitis B antigen in circulating immune complexes in acute and chronic hepatitis. Scand J Immunol (1977) 1.20
Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol (1992) 1.20
Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum (1982) 1.19
Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test. Br J Dermatol (2009) 1.19
Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med (1996) 1.19
Tissue distribution of dialysis amyloidosis. Clin Nephrol (1987) 1.19
Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. Am J Kidney Dis (1993) 1.18
Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int (1990) 1.18
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients. Lancet (1981) 1.18
Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis. Rheumatology (Oxford) (2000) 1.17
Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med (1995) 1.17
Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy. Nephron (1991) 1.17
Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. Immunology (1992) 1.16
Pregnancy in women with impaired renal function. Clin Nephrol (1997) 1.16
Coiled structure of the nucleocapsid of avian myeloblastosis virus. J Gen Virol (1970) 1.13
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid. J Rheumatol (1997) 1.13
Clinically available pharmacogenomics tests. Clin Pharmacol Ther (2009) 1.13
Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. Arthritis Rheum (1994) 1.12
CD11c+ eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion. J Immunol (2000) 1.12
IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse. Int Immunol (1996) 1.11
A marked drop in the incidence of the null allele of the B gene of the fourth component of complement (C4B*Q0) in elderly subjects: C4B*Q0 as a probable negative selection factor for survival. Hum Genet (1991) 1.08
A case of Enterocytozoon bieneusi infection in an HIV-negative renal transplant recipient. Eur J Clin Microbiol Infect Dis (2000) 1.07
Microtiter plate assay for phagocyte-derived taurine-chloramines. J Clin Lab Anal (1992) 1.07
Adenosine enhances IL-10 secretion by human monocytes. J Immunol (1996) 1.07
Hemodialysis-associated amyloidosis and beta-2 microglobulin. Clinical and immunohistochemical study. Am J Med (1987) 1.07
Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int (1998) 1.07
Control of severe hyperparathyroidism and regression of a brown tumour after treatment with i.v. alfacalcidol in a uraemic patient. Nephrol Dial Transplant (1996) 1.06
Detrimental effects of late referral in patients with chronic renal failure: a case-control study. Kidney Int Suppl (1993) 1.06
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med (1996) 1.06
Serum cytokine changes in systemic vasculitis. Immunology (1989) 1.05
Urinary stones in HIV-1-positive patients treated with indinavir. Lancet (1997) 1.04
Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg (1997) 1.04
Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J Immunol (2001) 1.03
[Infectious risks associated with blood exposure for traditional barbers and their customers in Morocco]. Sante (2005) 1.03
Anemia and secondary hyperparathyroidism. Arch Intern Med (1978) 1.02
Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol (2000) 1.02
Dynamics of fever and the cytokine network in systemic juvenile arthritis. Rev Rhum Engl Ed (1996) 1.01
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age. Clin Pharmacol Ther (2011) 1.00
Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol (1996) 1.00
Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells. J Clin Invest (1990) 1.00
One year follow-up of short dialysis with a membrane highly permeable to middle molecules. Proc Eur Dial Transplant Assoc (1973) 1.00
Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications. Arthritis Rheum (1995) 1.00
Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis. Ann Rheum Dis (2004) 1.00
Interleukin 7 induces preferential expansion of V beta 8.2+CD4-8- and V beta 8.2+CD4+8- murine thymocytes positively selected by class I molecules. J Exp Med (1994) 1.00
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study. Br J Cancer (2010) 0.99
Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int (1985) 0.99